Home Epigenic

Epigenic

In operation
Series B
Gene Editing Technology Developer
Basic
Enterprise Profile

Basic Information

Epigenic is a gene editing technology developer dedicated to regulating various diseases through epigenomic editing and creating the next generation of gene editing therapies. Using the company's exclusive patented epigenetic editing technology, it can simultaneously regulate the expression of multiple genes without altering the DNA sequence. The company is developing a variety of candidate products, including treatments for eye, neurodegenerative, metabolic, and rare diseases.
Epigenic Therapeutics, Inc.
Shanghai,China
15~50 people
September 29, 2021
chengkuan.song@epigenictx.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy
Technology
Gene Editing
Concept
Ophthalmology # Nervous System Diseases Rare Diseases
Application Scenarios
Innovative Drugs